These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11363510)

  • 21. Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
    Hardy WD
    AIDS Clin Rev; 1991; ():145-80. PubMed ID: 1651099
    [No Abstract]   [Full Text] [Related]  

  • 22. Current status of prophylaxis for opportunistic infections in HIV-infected patients.
    Decker CF; Masur H
    AIDS; 1994 Jan; 8(1):11-20. PubMed ID: 8011221
    [No Abstract]   [Full Text] [Related]  

  • 23. [The stakes in preventing opportunistic MAI infections in AIDS. From an interview with Dr. Patrick Philibert].
    Philibert P
    Allerg Immunol (Paris); 1994 Apr; 26(4):145-8. PubMed ID: 7913323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discontinuation of Mycobacterium avium complex prophylaxis in patients with a rise in CD4 cell count following highly active antiretroviral therapy.
    Gill J; Moyle G; Nelson M
    AIDS; 1998 Apr; 12(6):680. PubMed ID: 9583614
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in prevention and treatment of MAC.
    Cheng B
    PI Perspect; 1995 Dec; (no 17):11. PubMed ID: 11363104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.
    Zeller V; Truffot C; Agher R; Bossi P; Tubiana R; Caumes E; Jouan M; Bricaire F; Katlama C
    Clin Infect Dis; 2002 Mar; 34(5):662-7. PubMed ID: 11810599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple opportunistic pathogen prophylaxis for patients with advanced HIV disease: an overview.
    Jacobson MA
    AIDS Clin Rev; 1995-1996; ():47-63. PubMed ID: 7488560
    [No Abstract]   [Full Text] [Related]  

  • 28. Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents.
    Cinti SK; Kaul DR; Sax PE; Crane LR; Kazanjian PH
    Clin Infect Dis; 2000 Mar; 30(3):511-4. PubMed ID: 10722436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium avium-complex pericarditis: a case of unmasking immune reconstitution inflammatory syndrome.
    Babu TM; Laguio M; Luque AE; Larppanichpoonphol P
    Int J STD AIDS; 2014 Feb; 25(2):148-51. PubMed ID: 23970640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluconazole and enhanced effect of rifabutin prophylaxis.
    Narang PK; Trapnell CB; Schoenfelder JR; Lavelle JP; Bianchine JR
    N Engl J Med; 1994 May; 330(18):1316-7. PubMed ID: 7695673
    [No Abstract]   [Full Text] [Related]  

  • 31. New drug applications sought.
    AIDS Alert; 1995 Sep; 10(9):119-20. PubMed ID: 11362777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical impact of combination antiretroviral therapy].
    Gatanaga H
    Nihon Rinsho; 2002 Apr; 60(4):739-44. PubMed ID: 11968781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mycobacterium avium infection in HIV-infected patients: epidemiology, diagnosis, prevention and treatment].
    Schneider MM; Reiss P; Borleffs JC; Rozenberg-Arska M; Hoepelman IM
    Ned Tijdschr Geneeskd; 1997 Jan; 141(2):80-3. PubMed ID: 9036351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OI prophylaxis in antiretroviral responders: stay the course or bite the bullet?
    Currier JS
    AIDS Clin Care; 1998 Oct; 10(10):73-5, 79-80. PubMed ID: 11365859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rifabutin prophylaxis and uveitis.
    Fuller JD; Stanfield LE; Craven DE
    N Engl J Med; 1994 May; 330(18):1315-6. PubMed ID: 8145794
    [No Abstract]   [Full Text] [Related]  

  • 36. AIDS related opportunistic infections, going but not gone.
    Samuel R; Bettiker RL; Suh B
    Arch Pharm Res; 2002 Jun; 25(3):215-28. PubMed ID: 12135090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opportunistic infections update.
    PI Perspect; 1996 Sep; (No 19):15-6. PubMed ID: 11363899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis against opportunistic infections in patients infected with the human immunodeficiency virus.
    Cheever LW; Chaisson RE; Gallant JE
    West J Med; 1996; 165(1-2):67-73. PubMed ID: 8855697
    [No Abstract]   [Full Text] [Related]  

  • 39. Update on opportunistic infections.
    Feinberg J; Leport C; Reiss P
    AIDS; 1991; 5 Suppl 2():S195-202. PubMed ID: 1668981
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mycobacterium avium infection in HIV-infected patients: epidemiology, diagnosis, prevention and treatment].
    Blaauwwiekel EE; Sprenger HG; Weits J
    Ned Tijdschr Geneeskd; 1997 Mar; 141(12):602-3. PubMed ID: 9190533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.